Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent

Detalles Bibliográficos
Autores principales: Huseynov, Aydin, Behnes, Michael, Ansari, Uzair, Baumann, Stefan, Lossnitzer, Dirk, El-Battrawy, Ibrahim, Fastner, Christian, Borggrefe, Martin, Akin, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2019
Materias:
Letter To The Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911800/
https://www.ncbi.nlm.nih.gov/pubmed/31853250
http://dx.doi.org/10.11909/j.issn.1671-5411.2019.11.001
_version_ 1783479326353653760
author Huseynov, Aydin
Behnes, Michael
Ansari, Uzair
Baumann, Stefan
Lossnitzer, Dirk
El-Battrawy, Ibrahim
Fastner, Christian
Borggrefe, Martin
Akin, Ibrahim
author_facet Huseynov, Aydin
Behnes, Michael
Ansari, Uzair
Baumann, Stefan
Lossnitzer, Dirk
El-Battrawy, Ibrahim
Fastner, Christian
Borggrefe, Martin
Akin, Ibrahim
author_sort Huseynov, Aydin
collection PubMed
description
format Online
Article
Text
id pubmed-6911800
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Science Press
record_format MEDLINE/PubMed
spelling pubmed-69118002019-12-18 Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent Huseynov, Aydin Behnes, Michael Ansari, Uzair Baumann, Stefan Lossnitzer, Dirk El-Battrawy, Ibrahim Fastner, Christian Borggrefe, Martin Akin, Ibrahim J Geriatr Cardiol Letter To The Editor Science Press 2019-11 /pmc/articles/PMC6911800/ /pubmed/31853250 http://dx.doi.org/10.11909/j.issn.1671-5411.2019.11.001 Text en Institute of Geriatric Cardiology http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission.
spellingShingle Letter To The Editor
Huseynov, Aydin
Behnes, Michael
Ansari, Uzair
Baumann, Stefan
Lossnitzer, Dirk
El-Battrawy, Ibrahim
Fastner, Christian
Borggrefe, Martin
Akin, Ibrahim
Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent
title Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent
title_full Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent
title_fullStr Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent
title_full_unstemmed Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent
title_short Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent
title_sort optimal duration for dual antiplatelet therapy with combo dual therapy stent
topic Letter To The Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911800/
https://www.ncbi.nlm.nih.gov/pubmed/31853250
http://dx.doi.org/10.11909/j.issn.1671-5411.2019.11.001
work_keys_str_mv AT huseynovaydin optimaldurationfordualantiplatelettherapywithcombodualtherapystent
AT behnesmichael optimaldurationfordualantiplatelettherapywithcombodualtherapystent
AT ansariuzair optimaldurationfordualantiplatelettherapywithcombodualtherapystent
AT baumannstefan optimaldurationfordualantiplatelettherapywithcombodualtherapystent
AT lossnitzerdirk optimaldurationfordualantiplatelettherapywithcombodualtherapystent
AT elbattrawyibrahim optimaldurationfordualantiplatelettherapywithcombodualtherapystent
AT fastnerchristian optimaldurationfordualantiplatelettherapywithcombodualtherapystent
AT borggrefemartin optimaldurationfordualantiplatelettherapywithcombodualtherapystent
AT akinibrahim optimaldurationfordualantiplatelettherapywithcombodualtherapystent

Ejemplares similares